Media Partners

An online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field. Bioconjugate Insights provides a unique platform for the bioconjugation community’s experts to explore key current trends, challenges, and breakthroughs. Core areas for coverage include, but are not limited to:

• ADCs
• Antibody-oligonucleotide conjugates (AOCs)
• Bispecific ADCs (BsADCs)
• Conjugated vaccines
• Diagnostic and imaging tools
• Enzyme conjugates
• Nanoparticle conjugates
• Polymer conjugates – including PEGylation
• Protein and peptide conjugates (PPCs)
• Radioconjugates
• Targeted drug delivery
• Theranostics

A blend of in-depth scientific and technical detail with ‘big picture’ strategic analysis provides the perfect platform to contextualize recent progress, address current issues, and share insight into future directions for this rapidly developing sector.

Additionally, Bioconjugate Insights' comprehensive scope and coverage spans engineering and design, manufacturing and supply chain, preclinical and clinical R&D, regulation, financing, market access, and more.

It is the first and only dedicated digital content channel specifically designed to keep industry and academic professionals up to date with this truly global sector’s evolution on a genuinely worldwide scale.